Angeles Wealth Management’s Takeda Pharmaceutical TAK Stock Holding History

Angeles Wealth Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$289K	Buy	17,800 +4,265	+32%	+$70.6K	0.01%	394
2026 Q1	$251K	Buy	13,535 +1,921	+17%	+$33.7K	0.01%	358
2025 Q4	$181K	Sell	11,614 -2,433	-17%	-$34.8K	0.01%	374
2025 Q3	$206K	Buy	14,047 +1,097	+8%	+$16.3K	0.01%	328
2025 Q2	$200K	Buy	+12,950	New	+$191K	0.01%	338
2022 Q4	–	Sell	-11,402	Closed	-$148K	–	224
2022 Q3	$148K	Buy	+11,402	New	+$159K	0.03%	175

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Angeles Wealth Management's TAK Position: Q2 2026 in Review

Angeles Wealth Management increased its Takeda Pharmaceutical (TAK) stake by 32% in Q2 2026, buying an estimated $70.6K and bringing the position to 17,800 shares worth $289K. The position accounts for 0.01% of the portfolio, ranked #394.

Angeles Wealth Management first reported a position in TAK in Q3 2022 and has held it in 6 quarters since. 378 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Angeles Wealth Management held 17,800 shares of Takeda Pharmaceutical worth $289K as of Q2 2026.
Angeles Wealth Management bought 4,265 Takeda Pharmaceutical shares in Q2 2026, an estimated $70.6K.
Takeda Pharmaceutical made up 0.01% of Angeles Wealth Management's portfolio in Q2 2026, its #394 holding.
Angeles Wealth Management first reported a position in Takeda Pharmaceutical in Q3 2022 and has held it in 6 quarters since.
378 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Angeles Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.